大行評級 | 瑞銀:料長實出售多項資產後淨負債率降至0.3% 評級為中性
格隆匯3月14日丨瑞銀髮研報提到,長實集團(1113.HK)以總代價約12.09億元(英鎊.下同)(約123.82億港元)出售英國倫敦名為“5 Broadgate”大廈物業。集團於2018年6月以10億英鎊購入5 Broadgate物業,該項投資三年半以來的總回報為約48億港元,即45%%投資回報。該行予集團目標價52港元,評級為“中性”。
瑞銀預計,長實自去年6月出售多項資產後,其淨負債率將從去年6月的13.3%大幅下降至只有0.3%。該行相信,如長實能成功出售其價值150億英鎊的英國電力資產UK Power Network 20%的股權,集團或有300億港元的淨現金流。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.